New Generation Aromatase Inhibitors in Breast Cancer: Weighing Out Potential Costs and Benefits

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.17, Iss.2, 2000-02, pp. : 121-132

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Risks and Benefits of Aromatase Inhibitors in Postmenopausal Breast Cancer

By Michaud L.B.

Drug Safety, Vol. 21, Iss. 4, 1999-10 ,pp. : 297-309

Adis International

Access to resources Recommend Favorite

The therapeutic potential of novel aromatase inhibitors in breast cancer

By Taylor P.D. Howell A.

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 3, 1999-03 ,pp. : 269-279

Informa Healthcare

Access to resources Recommend Favorite

Aromatase inhibitors and breast cancer prevention

By Litton Jennifer Keating Arun Banu K Brown Powel H Hortobagyi Gabriel N

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 3, 2012-02 ,pp. : 325-331

Informa Healthcare

Access to resources Recommend Favorite

Aromatase Inhibitors and Inactivators for Breast Cancer Therapy

By Lønning P.E.

Drugs & Aging, Vol. 19, Iss. 4, 2002-04 ,pp. : 277-298

Adis International

Access to resources Recommend Favorite

Aromatase Inhibitors in the Treatment of Postmenopausal Breast Cancer

By Bajetta E.

Drugs & Aging, Vol. 15, Iss. 4, 1999-10 ,pp. : 271-283

Adis International

Access to resources Recommend Favorite